Related Experiment Video
Updated: May 13, 2026

Retroviral Infection of Murine Embryonic Stem Cell Derived Embryoid Body Cells for Analysis of Hematopoietic Differentiation
Published on: October 20, 2014
Newly Identified Roles of PML in Stem Cell Biology
1Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research, Albert Einstein College of Medicine Bronx, NY, USA ; Department of Cell Biology, Albert Einstein College of Medicine Bronx, NY, USA ; Department of Medicine, Albert Einstein College of Medicine Bronx, NY, USA ; Albert Einstein Cancer Center, Albert Einstein College of Medicine Bronx, NY, USA.
Abstract:
It has long been believed that the tumor suppressor promyelocytic leukemia (PML), the core component of the nuclear substructures known as the PML-nuclear bodies, plays a key part in acute PML (APL), as it is first cloned at the breakpoint of the t(15;17) translocation typical of that disease. Research over the past decade, however, has radically changed our view of how this tumor suppressor is regulated, how it can be therapeutically targeted, and how it functions in a number of tissue systems. One noteworthy recent study, for instance, revealed that PML regulates the activation of fatty acid metabolism, and that this metabolic reprograming plays an essential role in cancer biology and stem cell biology through the control it exerts over stem cell fate decisions. These findings sparked exciting new investigations of PML as a critical "rheostat" responsible for fine-tuning tissue homeostasis, and thus created at the intersection of cancer and stem cell biology a new field of study with important therapeutic implications.
Insights
The tumor suppressor promyelocytic leukemia (PML) protein regulates fatty acid metabolism, impacting cancer and stem cell biology. This discovery opens new therapeutic avenues for tissue homeostasis and disease treatment.
Area of Science:
- Molecular Biology
- Cancer Biology
- Stem Cell Biology
- Metabolic Regulation
Background:
- The promyelocytic leukemia (PML) protein, a tumor suppressor and core component of PML-nuclear bodies, was initially linked to acute promyelocytic leukemia (APL) due to its presence at the t(15;17) translocation breakpoint.
- Recent research has significantly advanced our understanding of PML's regulation, therapeutic targeting, and diverse tissue functions, moving beyond its established role in APL.
Purpose of the Study:
- To investigate the role of PML in regulating metabolic pathways, specifically fatty acid metabolism.
- To explore the implications of PML-mediated metabolic reprogramming in cancer and stem cell biology.
- To understand PML's function in fine-tuning tissue homeostasis and its potential as a therapeutic target.
Main Methods:
- The abstract does not detail specific experimental methods but refers to a noteworthy recent study.
- The study likely involved molecular and cellular biology techniques to assess PML's regulatory functions and metabolic impacts.
Main Results:
- PML was revealed to regulate the activation of fatty acid metabolism.
- This metabolic reprogramming by PML plays a critical role in cancer biology and stem cell biology.
- PML influences stem cell fate decisions through its metabolic control.
Conclusions:
- PML acts as a critical 'rheostat' for fine-tuning tissue homeostasis.
- The findings establish a new field of study at the intersection of cancer and stem cell biology.
- PML represents a promising therapeutic target with significant implications for treating various diseases.
Related Concept Videos
Lineage Commitment
Regulation of Hematopoietic Stem Cells
Multipotency of Hematopoietic Stem Cells
Stem Cell Niche
Multipotency and Niche of Bulge Stem Cell
Induced Pluripotent Stem Cells
Somatic cells are...

